Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
12.51
+0.22 (1.79%)
Aug 21, 2026, 3:16 PM EDT - Market open

Core Laboratories Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.7422.719.1615.1215.4317.7
Cash & Short-Term Investments
22.7422.719.1615.1215.4317.7
Cash Growth
-27.10%18.50%26.70%-2.00%-12.85%28.23%
Accounts Receivable
108.82113.53111.76109.35106.9196.83
Other Receivables
7.277.2710.3213.728.199.91
Receivables
116.08120.8122.08123.07115.1106.74
Inventory
57.9654.559.471.760.4545.44
Prepaid Expenses
10.959.7310.188.1515.6714.06
Other Current Assets
6.636.9410.525.095.065.11
Total Current Assets
214.36214.67221.33223.14211.7189.06
Property, Plant & Equipment
153.26153.79153.55153.47157.41172.34
Long-Term Investments
-4.435.084.844.454.16
Goodwill
105.8105.7999.4599.4599.4599.45
Other Intangible Assets
6.757.126.46.937.488.14
Long-Term Deferred Tax Assets
70.5767.3869.6169.268.5770.46
Other Long-Term Assets
36.0430.8429.7129.3829.337.26
Total Assets
586.78584.01585.13586.4578.35580.85

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
40.1637.2834.5533.5145.8529.73
Accrued Expenses
25.2530.830.0124.7328.2526.76
Current Portion of Leases
11.9411.4610.6910.1811.712.34
Current Income Taxes Payable
1.624.269.717.283.036.5
Current Unearned Revenue
5.085.559.334.765.947.77
Other Current Liabilities
17.0116.688.167.658.367.68
Total Current Liabilities
101.05106.02102.4588.1103.1490.78
Long-Term Debt
113.86110.26126.11163.13172.39194.08
Long-Term Leases
39.3142.3143.3442.0838.3149.29
Long-Term Unearned Revenue
----0.020.44
Pension & Post-Retirement Benefits
-1.371.722.272.684.09
Long-Term Deferred Tax Liabilities
7.5589.0712.722.8824.34
Other Long-Term Liabilities
46.2343.8650.1348.3149.9956.84
Total Liabilities
308.01311.8332.81356.59389.4419.85

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.470.470.470.471.191.19
Additional Paid-In Capital
115.51110.25109.55110.01102.25101.12
Retained Earnings
176.91172.66144.86120.7685.9568.35
Treasury Stock
-14.54-11.59-2.54-1.45-1.36-4.08
Comprehensive Income & Other
-5.68-5.81-5.77-4.97-3.78-10.13
Total Common Equity
272.67265.99246.57224.82184.26156.45
Minority Interest
6.16.225.754.994.74.55
Shareholders' Equity
278.77272.21252.32229.81188.95161
Total Liabilities & Equity
586.78584.01585.13586.4578.35580.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
165.12164.02180.14215.39222.39255.71
Net Cash (Debt)
-142.38-141.32-160.99-200.27-206.96-238.01
Net Cash Growth
------
Net Cash Per Share
-3.05-3.00-3.38-4.21-4.42-5.10
Filing Date Shares Outstanding
45.8846.0546.8346.8646.6346.28
Total Common Shares Outstanding
45.8846.146.8346.8646.6346.35
Working Capital
113.31108.65118.89135.04108.5798.27
Book Value Per Share
5.945.775.274.803.953.38
Tangible Book Value
160.12153.08140.73118.4477.3348.87
Tangible Book Value Per Share
3.493.323.012.531.661.05
Land
-10.4110.410.6510.6511.4
Buildings
-123.51117.68120.55120.99120.07
Machinery
-286.23283.3284.23288.12285.95
SEC Filings: 10-K · 10-Q